E, N., JD, W., MA, W., Y, Y., GA, W., & TS, H. (2017). Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]. Dove Medical Press.
Cita Chicago Style (17a ed.)E, Nudleman, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, y Hassan TS. Worsening Anatomic Outcomes Following Aflibercept for Neovascular Age-related Macular Degeneration in Eyes Previously Well Controlled with Ranibizumab [Corrigendum]. Dove Medical Press, 2017.
Cita MLA (8a ed.)E, Nudleman, et al. Worsening Anatomic Outcomes Following Aflibercept for Neovascular Age-related Macular Degeneration in Eyes Previously Well Controlled with Ranibizumab [Corrigendum]. Dove Medical Press, 2017.
Precaución: Estas citas no son 100% exactas.